[Antiparkinsonian drugs]

Area of Science:

• Neurology
• Pharmacology

Context:

• Parkinson's disease (PD) management
• Levodopa as a primary treatment
• Challenges in long-term PD therapy

Purpose:

• To review the efficacy and side effects of levodopa in Parkinson's disease treatment
• To discuss alternative and adjuvant therapies for PD
• To explore emerging treatments for Parkinson's disease

Summary:

• Levodopa, combined with a dopa decarboxylase inhibitor, is the most effective drug for Parkinson's disease (PD), significantly improving motor symptoms like akinesia and rigidity and increasing life expectancy.
• Despite its benefits, long-term levodopa use can lead to difficult-to-manage side effects, including motor fluctuations, dyskinesias, and psychosis, requiring careful consideration of its risk-benefit profile.
• Anticholinergic drugs are used cautiously for tremor, while dopamine agonists serve as adjuvant therapy for levodopa's late side effects. Emerging treatments like selegiline, novel drug formulations, and advanced approaches such as brain grafts and infusions are under clinical evaluation.

Impact:

• Informs clinical decision-making regarding initial levodopa therapy for Parkinson's disease.
• Highlights the need for ongoing research into managing levodopa's late-onset side effects.
• Provides an overview of current and future therapeutic strategies for Parkinson's disease management.